Thelma Therapeutics

XKRX:015540 (Korea (the Republic of))  
â‚© 6410.00 (0%) Mar 24
At Loss
Market Cap:
â‚© 86.23B ($ 63.00M)
Enterprise V:
â‚© 86.23B ($ 63.00M)
Volume:
-
Avg Vol (2M):
-
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Thelma Therapeutics ( ) from 1990 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Thelma Therapeutics stock (XKRX:015540) PE ratio as of Jun 07 2024 is 0. More Details

Thelma Therapeutics (XKRX:015540) PE Ratio (TTM) Chart

To

Thelma Therapeutics (XKRX:015540) PE Ratio (TTM) Historical Data

Total 967
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 11
Thelma Therapeutics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-07 237.4 2023-01-23 237.4
2023-03-24 237.4 2023-01-20 237.4
2023-03-23 237.4 2023-01-19 237.4
2023-03-22 237.4 2023-01-18 237.4
2023-03-21 237.4 2023-01-17 237.4
2023-03-20 237.4 2023-01-16 237.4
2023-03-17 237.4 2023-01-13 237.4
2023-03-16 237.4 2023-01-12 237.4
2023-03-15 237.4 2023-01-11 237.4
2023-03-14 237.4 2023-01-10 237.4
2023-03-13 237.4 2023-01-09 237.4
2023-03-10 237.4 2023-01-06 237.4
2023-03-09 237.4 2023-01-05 237.4
2023-03-08 237.4 2023-01-04 237.4
2023-03-07 237.4 2023-01-03 237.4
2023-03-06 237.4 2023-01-02 237.4
2023-03-03 237.4 2022-12-30 237.4
2023-03-02 237.4 2022-12-29 237.4
2023-03-01 237.4 2022-12-28 237.4
2023-02-28 237.4 2022-12-27 237.4
2023-02-27 237.4 2022-12-26 237.4
2023-02-24 237.4 2022-12-23 237.4
2023-02-23 237.4 2022-12-22 237.4
2023-02-22 237.4 2022-12-21 237.4
2023-02-21 237.4 2022-12-20 237.4
2023-02-20 237.4 2022-12-19 237.4
2023-02-17 237.4 2022-12-16 237.4
2023-02-16 237.4 2022-12-15 237.4
2023-02-15 237.4 2022-12-14 237.4
2023-02-14 237.4 2022-12-13 237.4
2023-02-13 237.4 2022-12-12 237.4
2023-02-10 237.4 2022-12-09 237.4
2023-02-09 237.4 2022-12-08 237.4
2023-02-08 237.4 2022-12-07 237.4
2023-02-07 237.4 2022-12-06 237.4
2023-02-06 237.4 2022-12-05 237.4
2023-02-03 237.4 2022-12-02 237.4
2023-02-02 237.4 2022-12-01 237.4
2023-02-01 237.4 2022-11-30 237.4
2023-01-31 237.4 2022-11-29 237.4
2023-01-30 237.4 2022-11-28 237.4
2023-01-27 237.4 2022-11-25 237.4
2023-01-26 237.4 2022-11-24 237.4
2023-01-25 237.4 2022-11-23 237.4
2023-01-24 237.4 2022-11-22 237.4

Thelma Therapeutics (XKRX:015540) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Thelma Therapeutics, formerly Medipartner Biotechnology is a South Korean company engaged in providing hospital management support, dental material distribution, medical devices manufacturing, and development of new materials.